対話型分析
マクロ分析
個別銘柄
アルファラボ
ユーティリティ
Menu
マイアクティビティ
JA
ログイン
JA
急落分析
/
Endra Life Sciences Inc.
/
2026-06-25
▼ PLUNGE
Endra Life Sciences Inc.
-31.4%
NDRA
NASDAQ
Healthcare
2026-06-25
4.3
終値
6.27
前日終値
-31.42%
騰落率
8.3x
出来高比
急落の理由
2026년 6월 1일, Ascendiant Capital은 ENDRA Life Sciences에 대해 '매수(Buy)' 의견을 유지했으나 목표 주가를 25달러로 하향 조정했다.
·
2026년 6월 1일, Ascendiant Capital은 ENDRA Life Sciences에 대해 '매수(Buy)' 의견을 유지했으나 목표 주가를 25달러로 하향 조정했다.
関連ニュース
Ascendiant Capital Maintains Buy on ENDRA Life Sciences, Lowers Price Target to $25 - ENDRA Life Sciences
Benzinga
2026-06-01
Neumora Therapeutics to Participate in 25th Annual Needham Virtu
Gurufocus
2026-04-06
Neumora lines up April 13 Needham healthcare conference webcast
Stocktitan
2026-04-06
Deal Dispatch: Estée Lauder Considers Merger, KKR Buys Nothing Bundt Cakes, Amazon Acquires Fauna Robotics - Abbott Laboratories (NYSE:ABT), Amazon (NASDAQ:AMZN)
Benzinga
2026-03-27
Enveric Biosciences shares are trading higher after the FDA announced accelerated efforts to advance trea
Benzinga
2026-04-24
テクニカル分析
シグナル
MACD強気
SMA20下
主要指標
43.66
RSI (14)
4.88
SMA 20
3.78
Bollinger Lower
5.98
Bollinger Upper
4.88
Bollinger Mid
0.00
MACD
-0.06
MACD Signal
0.07
MACD Hist
銘柄詳細を見る
急騰銘柄一覧へ
ホーム
チャット
資産
履歴
メニュー
Endra Life Sciences Inc. +-31.4% 急騰分析 (2026-06-25) | Alpha Lenz